Source: Annales Pharmaceutiques Francaises
Area: Evidence > Medicines Management > References
Introduction: Ophtalmic infections and inflammations are often encountered during hospitalisation. They require the preparation of 'fortified' ophthalmic solutions, i.e. pharmaceutical ophthalmic solutions which have a higher concentration of the active substance. Data on physicochemical stabilities are modified and it is therefore essential to collect the results of the various publications on this subject.
Method: In 2006, an initial literature review was undertaken to identify the molecules mostly used in the preparation of 'fortified' ophthalmic solutions in hospital. A second review of the literature in 2010 has expanded our knowledge in this area.
Results: Two new drugs have entered the summary table: amikacin and ticarcillin disodium. Date on 12 molecules already included in 2006 were updated to improve clinical practice. A review of the literature was undertaken in order to collect results for the molecules ...